Canada Markets close in 5 hrs 31 mins

PFE Jan 2024 65.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.06000.0000 (0.00%)
As of 02:58PM EDT. Market open.
Full screen
Previous Close0.0600
Open0.0600
Bid0.0500
Ask0.1000
Strike65.00
Expire Date2024-01-19
Day's Range0.0600 - 0.0600
Contract RangeN/A
Volume1
Open Interest5.51k
  • Reuters

    UPDATE 2-J&J bows out of RSV vaccine race after scrapping trial

    Johnson & Johnson said it will discontinue the late-stage study of its experimental respiratory syncytial virus (RSV) adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against the virus. J&J made the decision in order to "to focus on medicines with the greatest potential benefit to patients," the company said on Wednesday. J&J started the study following positive results from a mid-stage trial, which showed the vaccine was 80% effective in protecting against lower respiratory tract disease caused by RSV.

  • Motley Fool

    Better Growth Stock: AbbVie vs. Pfizer

    AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two of the world's biggest pharmaceutical companies, and the similarities don't end there. The case for AbbVie as a growth stock can't avoid two issues: the decline of Humira, and the stagnation of its oncology portfolio.

  • CNW Group

    CIBC introduces additional Canadian Depositary Receipts ("CDRs")

    CIBC today announced the addition of six new Canadian Depositary Receipts ("CDRs"), now listed on the NEO Exchange.